Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006;45(1):1-4.
doi: 10.2169/internalmedicine.45.1491. Epub 2006 Feb 1.

Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack

Hitoshi Aizawa  1 , Yoshihiro Makita, Kazuhiro Sumitomo, Yoko Aburakawa, Takayuki Katayama, Setsu Nakatani-Enomoto, Yasuhiro Suzuki, Kazuhiko Fujiwara, Hiroyuki Enomoto, Kenji Kuroda, Takashi Kimura, Osamu Yahara, Satoshi Koyama, Junichi Maruyama, Masao Nakamura, Naoyuki Hasebe, Kenjiro Kikuchi
Affiliations
Free article

Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack

Hitoshi Aizawa et al. Intern Med. 2006.
Free article

Abstract

Objective: Treatment with a free radical scavenger could be a new option for ischemic brain attack, however, little is known about the alteration of oxidative stress markers induced by edaravone, a novel free radical scavenger, in human ischemic brain attack.

Methods: We investigated the effects of edaravone on the oxidative stress markers in patients with ischemic brain attack. Twenty-one patients with ischemic brain attack and 19 controls were enrolled in this study. Blood samples were obtained just before and soon after the first administration of edaravone (30 mg) or ozagrel (40 mg). Intracellular reactive oxygen species of neutrophils were measured using 6-carboxy-2', 7'-dichlorodihydrofluorescin diacetate and a fluorescence-activated cell sorter. Superoxide from neutrophils, induced by phorbol myristate acetate (PMA), was determined by luminol-amplified chemiluminescence assay.

Results: Treatment with 30 mg of edaravone significantly decreased the intracellular reactive oxygen species (ROS) of neutrophils (Wilcoxon test, p=0.0001) and PMA-induced superoxide produced by neutrophils (Wilcoxon test, p=0.001). Ozagrel did not alter the intracellular ROS or superoxide production of neutrophils.

Conclusion: Reduction of intracellular ROS and suppression of superoxide production in neutrophils provide a potential explanation for the clinical efficacy of edaravone in patients with ischemic brain attack.

PubMed Disclaimer